Advisory Advocates »

ResMed shares owned by Advisory Advocates

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Advisory Advocates from 13F filings

Historical chart of Advisory Advocates investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Advisory Advocates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Advisory Advocates

Quarter filed Position value Share count Share price at filing
2026-03-31 $234k 1.0k 224.48
2025-12-31 $218k 904 240.87

More positions owned by Advisory Advocates

First Tr Exch Traded Fd Iii Ft Vest Smid (SDVD)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Nuveen Equity Premium and Growth Fund (SPXX)
First Tr Exchange-traded Ft Vest Ris (RDVI)
Cohen & Steers infrastucture Fund (UTF)
Columbia Seligm Prem Tech Gr (STK)
Apple (AAPL)
Adams Express Company (ADX)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)
Eaton Vance Tax Managed Buy Write Opport (ETV)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Vanguard World Inf Tech Etf (VGT)
Royce Value Trust (RVT)
Amazon (AMZN)

View all positions for Advisory Advocates

Top funds holding ResMed

Vanguard Group
BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Morgan Stanley
Invesco
Northern Trust
First Trust Advisors
Deutsche Bank Aktiengesellschaft
Swedbank AB
Charles Schwab Investment Management
Amundi

View all funds holding ResMed